LONDON (Thomson Financial) - Lombard Medical Technologies PLC said it has received continued CE Mark approval for a reconfiguration of its endostapler, EndoRefix, as well as conditional FDA approval for its investigational device exemptions (IDE) application for the product. CE Mark approval is an integral step towards launching a medical device in the European Union.
